Chemomab Therapeutics Ltd. (CMMB) stock

CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 5/30

$1.53+0.13 (+9.29%)

Close on Nov 13, 2026Market cap $11.00MP/E 1.1Yield –

Chemomab Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Chemomab Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?